About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 409 blog entries.

Effect of frailty on postoperative complications, mortality, and survival in older patients with non-metastatic colon cancer: A systematic review and meta-analysis

2023-10-13T14:20:14+02:00

Mª. Rosario Moreno-Carmona Mateu Serra-Prat Stephanie A. Riera Oscar Estrada Tarsila Ferro Rosa Querol Published:October 06, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101639

Effect of frailty on postoperative complications, mortality, and survival in older patients with non-metastatic colon cancer: A systematic review and meta-analysis2023-10-13T14:20:14+02:00

Introducing the Latest GerOnTe Project Newsletter: Enhancing Well-being for Older Multimorbid Patients

2025-03-19T20:44:48+01:00

GerOnTe is a 5-year research and innovation project (April 2021 to March 2026) funded by the European Union within the H2020 Research and Innovation Programme framework. Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patients The GerOnTe Project aims to improve quality of life – defined as well-being on three levels: global health status, physical functioning and social functioning- for older multimorbid patients while reducing overall care costs. To this end, GerOnTe is co-designing, testing, and preparing to deploy an innovative, cost-effective, patient-centred holistic health management system. This edition of the Newsletter includes: Updates from the research centre partners. Team publication information. Learn more about the project itself. And so much more.   View the latest GerOnTe Project Newsletter. More information about SIOG's stake in the GerOnTe Project. General information about the GerOnTe Project. 

Introducing the Latest GerOnTe Project Newsletter: Enhancing Well-being for Older Multimorbid Patients2025-03-19T20:44:48+01:00

Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG)

2025-03-19T20:45:29+01:00

Martine Extermann Andrew Artz Maite Antonio Rebollo Heidi D. Klepin Utz Krug Kah Poh Loh Alice S. Mims Nina Neuendorff Valeria Santini Reinhard Stauder Norbert Vey on behalf of SIOG Published: September 21, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101626

Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG)2025-03-19T20:45:29+01:00

Clinical validation of SARC-F by proxy as a practical tool to evaluate sarcopenia in dependent older adults

2023-09-27T14:23:44+02:00

Serdar Ozkok Meryem Merve Oren Caglar Ozer Aydin Humeyra Ozalp Cihan Kilic Yasagul Koc Hafize Dogan Onder Yuksel Eryigit Mehmet Akif Karan Gulistan Bahat Published: September 21, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101630

Clinical validation of SARC-F by proxy as a practical tool to evaluate sarcopenia in dependent older adults2023-09-27T14:23:44+02:00

Rethinking care management for older adults with cancer: Proposals from the “PRIORITES AGE CANCER” French group

2023-09-11T14:00:37+02:00

Angéline Galvin Nicolas Bertrand Rabia Boulahssass Laure De Decker Etienne Dorval Béatrice Clairaz Monique Castaignède Loic Mourey Capucine Baldini Eric Bauvin Béatrice Jacques Isabelle Mallon Isabelle Durand-Zaleski Olivier Guérin Sadek Krouri Pierre Soubeyran DOI:https://doi.org/10.1016/j.jgo.2023.101608

Rethinking care management for older adults with cancer: Proposals from the “PRIORITES AGE CANCER” French group2023-09-11T14:00:37+02:00

Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative

2023-09-11T13:58:25+02:00

Angéline Galvin Pierre Soubeyran Etienne Brain Kwok-Leung Cheung Marije E. Hamaker Ravindran Kanesvaran Murielle Mauer Supriya Mohile Isacco Montroni Martine Puts Siri Rostoft Hans Wildiers Simone Mathoulin-Pélissier Carine Bellera DOI:https://doi.org/10.1016/j.jgo.2023.101611

Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative2023-09-11T13:58:25+02:00

Medication assessment in older adults with cancer – Current practices in clinical pharmacy

2023-08-17T18:13:44+02:00

INTRODUCTION Clinical pharmacists, especially those working in oncology settings, play a pivotal role in medication management for older adults with cancer. Clinical pharmacists conduct structured medication assessments, which can include adverse effect assessment, interaction assessments, adherence monitoring, medication reconciliation, and in certain jurisdictions, prescribing and deprescribing. Pharmacists offer the Geriatric Oncology MDT suggestions to enhance medication safety, taking multiple factors into consideration, including the patient's age, comorbidities, and factors influencing drug metabolism and elimination. The SIOG Nursing and Allied Health Interest Group have recently published a perspective paper highlighting the role of clinical pharmacists in geriatric oncology[1]. We sat down with the lead author, Darren Walsh, pharmacist in University Hospital Waterford (Ireland) to discuss the growing recognition of clinical pharmacy as a key component of a wider multidisciplinary team within Geriatric Oncology. Roles and Responsibilities of Clinical Pharmacists Could you discuss the roles and responsibilities of clinical pharmacists in a [...]

Medication assessment in older adults with cancer – Current practices in clinical pharmacy2023-08-17T18:13:44+02:00
Go to Top